Arphra/Issuer/VRTX

VRTX

Vertex Pharmaceuticals Incorporated

HealthcareBiotechnologyUSUSD

$447.54

+0.50%Live · FMPMay 29, 2026

AI Brief

Market cap

$113.59B

52w range

362.50 – 507.92

P / E

—

EPS

—

Volume

1.89M

Revenue · FY

$12.07B

+9.57% YoY

AI Issuer Brief

Arphra AI

Loading cached brief…

Insider · 30d

Bought

0 txns

Sold

$8.21M

10 txns

Net flow

−$8.21M

Full history →

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$425.84

Change

-4.40%

Period high

$499.17

Period low

$366.54

Period start

$445.432025-06-02

Through 2026-05-04

Peers

Price change · trailing returns

Live · FMP

1D	5D	1M	3M	6M	YTD	1Y	3Y	5Y	10Y	Max
-0.10%	+2.18%	+4.72%	-9.92%	+3.21%	-1.28%	+0.47%	+38.31%	+113.45%	+380.45%	+9845.33%

Aftermarket

Live · FMP

May 29, 11:52 PM

Last trade

$447.05

5 sh

Bid

$447.05

100 sh

Ask

$454.00

6 sh

Spread

$6.950

Fair value

Football field →

Weighted blend

$2,211.96

+394.25% vs spot

Recommendation

Strong Buy

15 of 16 methods

Method spread

4bull11bear

±5% threshold

Analyst PT consensus: $552.27 (+23.40%)

Total assets

$26.14B

Total debt

$3.88B

Cash & equiv

$5.09B

Operating CF

$3.63B

Free cash flow

$3.19B

Buybacks

-$2.02B

Analyst view

DB · price_targets + analyst_grades

Consensus target

$552.27

+23.40% upside

Low

$437.00

Median

$558.00

High

$612.00

Recent actions

0 ↑0 ↓8 hold

Apr 01, 2026
Mar 01, 2026
Feb 01, 2026
Jan 01, 2026
Dec 01, 2025

News

DB · news_items

Recent quarters

All financials →

Period	Revenue	Net income	EPS
Q4 Dec 2025	$3.23B	$1.19B	$4.65
Q3 Sep 2025	$3.08B	$1.08B	$4.20
Q2 Jun 2025	$2.96B	$1.03B	$3.99
Q1 Mar 2025	$2.77B	$646.3M	$2.49
Q4 Dec 2024	$2.91B	$913M	$3.50
Q3 Sep 2024	$2.77B	$1.05B	$4.01

Recent insiders

All →

Insider	Action	Shares	Value	Date
Bhatia Sangeeta N. director	Sell	318	$134.75K	May 04, 2026
Liu Joy officer: EVP and Chief Legal Officer	Sell	1,104	$469.22K	May 01, 2026
Liu Joy officer: EVP and Chief Legal Officer	Sell	978	$439.29K	Apr 01, 2026
Bozic Carmen officer: EVP and CMO	Sell	2,329	$1.05M	Mar 27, 2026
Bozic Carmen officer: EVP and CMO	Sell	2,329	$1.12M	Mar 13, 2026
McKechnie Duncan officer: EVP, Chief Commercial Officer	Sell	2,633	$1.31M	Mar 11, 2026

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2025	$12.07B	$4.76B	$3.95B	$15.32	+32.74%
FY 2024	$11.02B	-$232.9M	-$535.6M	$-2.08	-4.86%
FY 2023	$9.87B	$3.83B	$3.62B	$13.89	+36.68%
FY 2022	$8.93B	$4.31B	$3.32B	$12.82	+37.20%
FY 2021	$7.57B	$2.78B	$2.34B	$9.01	+30.92%